Deal History
Über uns
Die Firma
Team
Büros
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Aktienanalyse
Growth Equity
IPO Strategie und Vorbereitung
Industries
Business Services
Consumer & Internet
Industrial Technology
Healthcare
Software
Energy & Infrastructure
Karriere
Events
Insights
News
Company News
Deal News
In den Medien
Newsletter
Kontakt
Newsletter
DE
INT
DA
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company News
Deal News
Equity Research
Events
In den Medien
Insights
Märkte
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
27 Mai 2026
Equity research Candles Scandinavia: Manufacturing and brand integration on track
Equity Research
Candles Scandinavia
25 Mai 2026
Equity research Zinzino Q1 2026: Solid operating leverage
Equity Research
Zinzino
22 Mai 2026
Equity research, Zinzino Q1 2026: First impression - Healthy margin trend continues
Equity Research
Zinzino
21 Mai 2026
Equity research WPTG, Q1 2026: Platform momentum builds on all fronts
Equity Research
White Pearl Technology Group
21 Mai 2026
Equity research Angler Gaming, Q1 2026: Growth and margin expansion signals inflection point
Equity Research
Angler Gaming
20 Mai 2026
Equity research Angler Gaming, Q1 2026: Profitability beats across the board on maturing B2B model
Equity Research
Angler Gaming
18 Mai 2026
Equity Research KlaraBo: A larger real estate company can trigger a higher valuation
Equity Research
KlaraBo
12 Mai 2026
Equity research Elicera Therapeutics, Q1 2026: Stepping up following progress
Equity Research
Elicera Therapeutics
11 Mai 2026
Equity research Viva Wine Group, Q1 2026: Nordics shine in a slow market
Equity Research
Viva Wine Group
11 Mai 2026
Equity research Immunovia Q1 2026: Initial commercialisation phase on track
Equity Research
Immunovia
08 Mai 2026
Equity research Candles Scandinavia, Q1 2026: A scent of synergies
Equity Research
Candles Scandinavia
08 Mai 2026
Equity Research ALM Equity, Q1 2026: Additional construction starts in 2026
Equity Research
ALM Equity
07 Mai 2026
Equity research Candles, Q1 2026: On track but with margins lagging as the Örebro bet takes shape
Equity Research
Candles Scandinavia
07 Mai 2026
Equity research Viva Wine Group Q1 2026: Organic growth but slightly softer EBITA margin in a slow market
Equity Research
Viva Wine Group
07 Mai 2026
Equity Research ALM Equity Q1 2026: Despite low revenue, there was a positive gross profit
Equity Research
ALM Equity
30 Apr 2026
Equity Research KlaraBo, Q1 2026: A cold quarter, but continued value increases
Equity Research
KlaraBo
29 Apr 2026
Equity research Enrad, Q1 2026: A sluggish start, but the case remains intact
Equity Research
Enrad
29 Apr 2026
Equity Research KlaraBo, Q1 2026: Larger value increases than expected
Equity Research
KlaraBo
29 Apr 2026
Equity research Svenska Aerogel, Q1 2026: Rights issue and focus on upcoming catalysts
Equity Research
Svenska Aerogel
24 Apr 2026
Equity research CDON AB Q1 2026: Building on solid growth momentum
Equity Research
CDON
1
2
3
…
64